10x Genomics
Navigation
Products
Products
Single Cell Gene Expression
with CRISPR Screening & Cell Surface Protein
Single Cell Immune Profiling
with Antigen Specificity & Cell Surface Protein
Single Cell Multiome ATAC + Gene Expression
Single Cell ATAC
Single Cell CNV
Spatial Gene Expression
with Immunofluorescence
Spatial Proteomics
Targeted Gene Expression
Linked-Reads Genomics
Product News
Product Updates
Instruments
Chromium Controller
Chromium Connect
Software
Cloud Analysis
Loupe Browser
Applications
CRISPR Screening
Multiomic Cytometry
Immune Receptor Mapping
Technology
Next GEM Technology
Visium Technology
In situ Technology
Compatible Products
Find 10x Compatible Products
Certified Service Providers
Find a Service Provider
Become a Service Provider
Area of Interest
Area of Interest
COVID-19
Immunology
Cancer
Neuroscience
Resources
Resources
Publications
Datasets
Videos
Libraries
10x University
10x-pert Workshop Series
Support Documentation
Customer Developed Protocols
Community
Blog
Clinical Translational Network
Support
Company
About Us
Our Mission
Our Team and Board
Distributors
Careers at 10x
Investors
Contact Us
News and Events
In the News
Blog
Events
10x-pert Workshop Series
Careers
Search
In the News
The Latest from 10x
Navigation
Press Releases
In the News
Blog
Events
The Scientist
2020 Top 10 Innovations
AlphaStreet
Current focus is on scaling up capabilities: 10x Genomics CEO Serge Saxonov
Genetic Engineering & Biotechnology News
Single Cell Multiomics: Simultaneous Epigenetic and Transcriptional Profiling
Technology Networks
Capturing the Transcriptome and the Epigenome Simultaneously in Single Cells
DNA Today
#132 DTC Series: Michael Schnall-Levin on Single Cell Sequencing
Genetic Engineering & Biotechnology News
Spatial: The Next Omics Frontier
Bloomberg
Covid-19 Vaccine Likely Early 2021, Says 10x Genomics CEO
BioSpace
10x Genomics Enters In Situ Analysis Market with Recent Acquisitions
GenomeWeb
10x Genomics Acquisitions Point Towards New In Situ Analyisis Platform
San Francisco Chronicle
Bay Area companies grapple with challenges of work-site testing
View more